Acetylsalicylic Acid, Caffeine

3 trials 1 recruiting NNeurology/Psychiatry

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

1 Sponsors

16 Countries

Phase III

Phase III: 3

Oversight events:

7 temporary halts 1 unexpected event across 2 trials

View oversight register →

Indications tested

Non-small cell lung cancer metastatic 2

Sponsors using this IMP

Merck Sharp & Dohme LLC 3

All trials

3 total

A clinical study to compare MK-2870 with pembrolizumab to pembrolizumab alone in people with lung cancer (MK-2870-007) Recruiting

2023-503376-24-00 Phase III 9 countries Merck Sharp & Dohme LLC
MK-2870 versus Chemotherapy in Previously Treated or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) with EGFR Mutations or Other … Ended

2023-503539-16-00 Phase III 7 countries Merck Sharp & Dohme LLC
MK-2870 in Post Platinum and Post Immunotherapy Endometrial Cancer Ended

2023-504816-14-00 Phase III 15 countries Merck Sharp & Dohme LLC

Showing 1–3 of 3 trials

← All drugs A–Z